An ISO 9001:2015 Certified Firm
A Leading and Comprehensive Intellectual Property (IP) Asset Management and Patent Support Practice
An ISO 9001:2015 Certified Firm
A Leading and Comprehensive Intellectual Property (IP) Asset Management and Patent Support Practice
Technology relates to an inexpensive and extremely effective synthetic lung surfactant, which has the potential to save the lives of babies, children and adults suffering with any of a range of respiratory and lung ailments. Synthetic formulation consisting of a combination of phospholipids and synthetic peptides which may be administered in liquid form or nebulised/aerosolised.
Status of Patent: PCT Patent Application WO2011/104621